EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Comparison of Remimazolam versus Sevoflurane on the Postoperative Quality of Recovery in Cervical Spine Surgery: A Prospective Randomized Controlled Double-Blind Trial

Jiwon Lee iD, Dong Woo Han, Na Young Kim iD, Keun-Su Kim, Yunil Yang, Juyeon Yang, Hye Sun Lee iD, Myoung Hwa Kim

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s441622 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Jiwon Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Gangnam Severance Hosp…. Hauptthemen laut MEDLINE: Postoperative Nausea and Vomiting, Propofol. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Remimazolam is a newly developed ultra-short-acting benzodiazepine. We compared overall functional recovery, including the postoperative Quality of Recovery-15 (QoR-15) questionnaire scores, between balanced inhalational anesthesia using sevoflurane and total intravenous anesthesia (TIVA) with remimazolam in patients undergoing anterior cervical discectomy and fusion (ACDF). Patients and Methods: Seventy-two patients were randomized to the remimazolam (group R) or sevoflurane (group S) group. The primary outcome was the total QoR-15 score on postoperative day (POD) 1. We also assessed the total QoR-15 score on POD2, sub-scores of the QoR-15, perioperative parameters, and postoperative recovery profiles. Group-time interaction effects on the QoR-15 and its sub-scores were analyzed using a linear mixed model.

Results

The total QoR-15 score on POD1 (120.2 in group R vs 114.3 in group S, P=0.189) was not statistically different between the groups. There were no significant group-time interaction effects on total QoR-15 scores. Instead, patients in group R showed significantly better sub-scores in psychological and postoperative nausea and vomiting (PONV) items on POD1, as well as a lower degree of PONV, than those in group S. Among the five dimensions of the QoR-15, a significant group-time interaction effect was observed for psychological support. Group R showed significantly less changeability in blood pressure and heart rate with a lower dose of intraoperatively administered vasopressor than group S.

Conclusion

Considering QoR-15, including PONV reduction, and intraoperative hemodynamic stability, remimazolam can be used as the novel and safe anesthetic agent for maintaining general anesthesia instead of sevoflurane in patients undergoing ACDF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postoperative Nausea and VomitingPropofolHumansAnesthesia, GeneralBenzodiazepinesCervical VertebraeProspective StudiesSevoflurane

Stichwörter der Autor:innen

cervical spine surgeryquality of recoveryremimazolamsevofluranetotal intravenous anesthesia

Substanzen

BenzodiazepinesPropofolremimazolamSevoflurane

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Neurosurgery, Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Jiwon Lee, Na Young Kim, Hye Sun Lee

Zitieren

APA

Lee, J., Han, D. W., Kim, N. Y., Kim, K. S., Yang, Y., Yang, J., Lee, H. S., & Kim, M. H. (2024). Comparison of Remimazolam versus Sevoflurane on the Postoperative Quality of Recovery in Cervical Spine Surgery: A Prospective Randomized Controlled Double-Blind Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s441622

Vancouver

Lee J, Han DW, Kim NY, Kim KS, Yang Y, Yang J, et al. Comparison of Remimazolam versus Sevoflurane on the Postoperative Quality of Recovery in Cervical Spine Surgery: A Prospective Randomized Controlled Double-Blind Trial. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s441622

BibTeX
@article{Lee2024,
  author = {Lee, Jiwon and Han, Dong Woo and Kim, Na Young and Kim, Keun-Su and Yang, Yunil and Yang, Juyeon and Lee, Hye Sun and Kim, Myoung Hwa},
  title = {Comparison of Remimazolam versus Sevoflurane on the Postoperative Quality of Recovery in Cervical Spine Surgery: A Prospective Randomized Controlled Double-Blind Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s441622}
}
Kostenlos starten →